Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Protara Therapeutics Inc.

    NASDAQ: TARA · Real-Time Price · USD
    3.17
    0.03 (0.96%)
    At close: Jun 16, 2025, 2:53 PM

    Protara Therapeutics Statistics

    Share Statistics

    Protara Therapeutics has 38.58M shares outstanding. The number of shares has increased by 78.57% in one year.

    Shares Outstanding

    n/a
    		 38.58M

    Shares Change (YoY)

    n/a
    		 78.57%

    Shares Change (QoQ)

    n/a
    		 7.13%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 34.42M

    Failed to Deliver (FTD) Shares

    n/a
    		 169,579

    FTD / Avg. Volume

    n/a
    		 47.81%

    Short Selling Information

    The latest short interest is 2.18M, so 5.66% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.18M

    Short % of Shares Out

    n/a
    		 5.66%

    Short % of Float

    n/a
    		 5.8%

    Short Ratio (days to cover)

    n/a
    		 7.21

    Valuation Ratios

    The PE ratio is -2.44 and the forward PE ratio is -1.91. Protara Therapeutics's PEG ratio is 0.06.

    PE Ratio

    n/a
    		 -2.44

    Forward PE

    n/a
    		 -1.91

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1

    PB Ratio

    n/a
    		 0.65

    P/FCF Ratio

    n/a
    		 -3.03

    PEG Ratio

    n/a
    		 0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Protara Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 15.71, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 15.71

    Quick Ratio

    n/a
    		 15.71

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 -0.09

    Debt / FCF

    n/a
    		 -0.12

    Interest Coverage

    n/a
    		 -11.78

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,592,714.29

    Employee Count

    n/a
    		 28

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 21.79% in the last 52 weeks. The beta is 1.36, so Protara Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.36

    52-Week Price Change

    n/a
    		 21.79%

    50-Day Moving Average

    n/a
    		 3.51

    200-Day Moving Average

    n/a
    		 3.52

    Relative Strength Index (RSI)

    n/a
    		 43.19

    Average Volume (20 Days)

    n/a
    		 354,684

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -49.15M

    Net Income

    n/a
    		 -44.6M

    EBITDA

    n/a
    		 -49.15M

    EBIT

    n/a
    		 -40.42M

    Earnings Per Share (EPS)

    n/a
    		 -2.17
    Full Income Statement

    Balance Sheet

    The company has 162.8M in cash and 4.48M in debt, giving a net cash position of 158.31M.

    Cash & Cash Equivalents

    n/a
    		 162.8M

    Total Debt

    n/a
    		 4.48M

    Net Cash

    n/a
    		 158.31M

    Retained Earnings

    n/a
    		 -244.98M

    Total Assets

    n/a
    		 168.56M

    Working Capital

    n/a
    		 119.51M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -35.81M and capital expenditures -63K, giving a free cash flow of -35.87M.

    Operating Cash Flow

    n/a
    		 -35.81M

    Capital Expenditures

    n/a
    		 -63K

    Free Cash Flow

    n/a
    		 -35.87M

    FCF Per Share

    n/a
    		 -1.74
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    TARA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TARA is $22, which is 602.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $22

    Price Target Difference

    n/a
    		 602.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 10, 2020. It was a backward split with a ratio of 1:40.

    Last Split Date

    n/a
    		 Jan 10, 2020

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:40

    Scores

    Altman Z-Score

    n/a
    		 4.9

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist